亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

The Glycylcyclines: A Comparative Review with the Tetracyclines

替加环素 四环素 米诺环素 微生物学 流出 抗生素 抗菌剂 医学 生物 遗传学
作者
George G. Zhanel,Kristen Homenuik,Kimberly A. Nichol,Ayman M. Noreddin,Lavern M. Vercaigne,John M. Embil,Alfred S. Gin,James A. Karlowsky,Daryl J. Hoban
出处
期刊:Drugs [Adis, Springer Healthcare]
卷期号:64 (1): 63-88 被引量:359
标识
DOI:10.2165/00003495-200464010-00005
摘要

The tetracycline class of antimicrobials exhibit a broad-spectrum of activity against numerous pathogens, including Gram-positive and Gram-negative bacteria, as well as atypical organisms. These compounds are bacteriostatic, and act by binding to the bacterial 30S ribosomal subunit and inhibiting protein synthesis. The tetracyclines have been used successfully for the treatment of a variety of infectious diseases including community-acquired respiratory tract infections and sexually transmitted diseases, as well in the management of acne. The use of tetracyclines for treating bacterial infections has been limited in recent years because of the emergence of resistant organisms with efflux and ribosomal protection mechanisms of resistance. Research to find tetracycline analogues that circumvented these resistance mechanisms has lead to the development of the glycylcyclines. The most developed glycylcycline is the 9-tert-butyl-glycylamido derivative of minocycline, otherwise known as tigecycline (GAR-936). The glycylcyclines exhibit antibacterial activities typical of earlier tetracyclines, but with more potent activity against tetracycline-resistant organisms with efflux and ribosomal protection mechanisms of resistance. The glycylcyclines are active against other resistant pathogens including methicillin-resistant staphylococci, penicillin-resistant Streptococcus pneumoniae, and vancomycin-resistant enterococci. Tigecycline is only available in an injectable formulation for clinical use unlike currently marketed tetracyclines that are available in oral dosage forms. Tigecycline has a significantly larger volume of distribution (> 10 L/kg) than the other tetracyclines (range of 0.14 to 1.6 L/kg). Protein binding is approximately 68%. Presently no human data are available describing the tissue penetration of tigecycline, although studies in rats using radiolabelled tigecycline demonstrated good penetration into tissues. Tigecycline has a half-life of 36 hours in humans, less than 15% of tigecycline is excreted unchanged in the urine. On the basis of available data, it does not appear that the pharmacokinetics of tigecycline are markedly influenced by patient gender or age. The pharmacodynamic parameter that best correlates with bacteriological eradication is time above minimum inhibitory concentration. Several animal studies have been published describing the efficacy of tigecycline. Human phase 1 and 2 clinical trials have been completed for tigecycline. Phase 2 studies have been conducted in patients with complicated skin and skin structure infections, and in patients with complicated intra-abdominal infections have been published as abstracts. Both studies concluded that tigecycline was efficacious and well tolerated. Few human data are available regarding the adverse effects or drug interactions resulting from tigecycline therapy; however, preliminary data report that tigecycline can be safely used, is well tolerated and that the adverse effects experienced were typical of the tetracyclines (i.e. nausea, vomiting and headache). Tigecycline appears to be a promising new antibacterial based on in vitro and pharmacokinetic/pharmacodynamic activity; however more clinical data are needed to fully evaluate its potential.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cc发布了新的文献求助10
7秒前
NexusExplorer的应助被康子浩采纳,获得10
7秒前
8秒前
从容飞雪完成签到,获得积分10
9秒前
14秒前
15秒前
ppp发布了新的文献求助10
19秒前
康子浩发布了新的文献求助10
19秒前
哇咔咔完成签到 ,获得积分10
22秒前
桐桐的应助被barrylee采纳,获得10
24秒前
完美世界的应助被科研通管家采纳,获得10
24秒前
打打的应助被科研通管家采纳,获得10
24秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
24秒前
脑洞疼的应助被科研通管家采纳,获得10
24秒前
丘比特的应助被科研通管家采纳,获得10
24秒前
香蕉觅云的应助被科研通管家采纳,获得10
24秒前
调皮怀薇的应助被科研通管家采纳,获得10
25秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
25秒前
科研通AI6.4的应助被cc采纳,获得10
25秒前
自然的绮山完成签到,获得积分10
30秒前
34秒前
barrylee完成签到,获得积分10
34秒前
SHUI发布了新的文献求助10
38秒前
车干完成签到,获得积分10
46秒前
Hello的应助被康子浩采纳,获得10
50秒前
53秒前
zhou完成签到,获得积分10
55秒前
58秒前
barrylee发布了新的文献求助10
58秒前
6666完成签到,获得积分10
59秒前
ppp发布了新的文献求助10
1分钟前
康子浩发布了新的文献求助10
1分钟前
Metx完成签到 ,获得积分10
1分钟前
走失方向的大肚腩完成签到,获得积分20
1分钟前
Sci666完成签到 ,获得积分10
1分钟前
freelancerart完成签到,获得积分10
1分钟前
缥缈的鸡翅完成签到,获得积分10
1分钟前
康子浩发布了新的文献求助10
1分钟前
威武的成协完成签到,获得积分10
1分钟前
6666发布了新的文献求助50
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165884
求助须知:如何正确求助?哪些是违规求助? 9559318
关于积分的说明 21749884
捐赠科研通 7756681
什么是DOI,文献DOI怎么找? 3429083
关于科研通互助平台的介绍 2553367
邀请新用户注册赠送积分活动 2473623